A2 BIOTHERAPEUTICS

Welcome to the Brand page for “A2 BIOTHERAPEUTICS”, which is offered here for T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer;a two bio therapeutics;biotherapeutics;provision of, and identification and development of, therapeutic targets, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer;.

Its status is currently believed to be active. Its class is unavailable. “A2 BIOTHERAPEUTICS” is believed to be currently owned by “A2 Biotherapeutics, Inc.”

Owner:
A2 BIOTHERAPEUTICS, INC.
Owner Details
Description:
T-cell pharmaceutical products for the treatment of cancer; therapeutic targets, proteins or protein complexes, for the treatment and prevention of cancer; therapeutic cells, for medical use, for the treatment and prevention of cancer; therapeutic proteins and therapeutic antibodies, for medical use, for the treatment and prevention of cancer in humans; therapeutics and cellular therapies in the nature of proteins and protein complexes for the treatment of cancer; biologics, proteins and protein complexes for in-vitro diagnostic use for the treatment of cancer;A TWO BIO THERAPEUTICS;BIOTHERAPEUTICS;Provision of, and identification and development of, therapeutic targets, proteins and protein complexes, for others for the treatment and prevention of cancer; development of therapeutics and cellular therapies, pharmaceutical, biological and medical therapies for the treatment of cancer; biotechnology research, development, testing and analysis for the treatment of cancer; Scientific research and development services; providing scientific information in the fields of treatment and prevention of cancer;
Categories: T CELL PHARMACEUTICAL PRODUCTS